CURIS, INC. Operating Lease Cost
CURIS, INC. (CRIS) reported Operating Lease Cost of $1.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-03-24
- CURIS, INC. operating lease, cost for the quarter ending 2020-12-31 was $336.00K, a 66.34% increase year-over-year.
- CURIS, INC. operating lease, cost for the quarter ending 2020-09-30 was $400.00K, a 33.33% increase year-over-year.
- CURIS, INC. operating lease, cost for the quarter ending 2020-06-30 was $500.00K, a 66.67% increase year-over-year.
- CURIS, INC. operating lease, cost for the quarter ending 2019-12-31 was $202.00K.
- CURIS, INC. operating lease, cost for fiscal 2025 was $1.50M, a 4.53% decline from fiscal 2024.
- CURIS, INC. operating lease, cost for fiscal 2024 was $1.57M, a 5.95% decline from fiscal 2023.
- CURIS, INC. operating lease, cost for fiscal 2023 was $1.67M, a 6.12% increase from fiscal 2022.
- CURIS, INC. operating lease, cost for fiscal 2022 was $1.57M, a 15.96% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 6 month as first filed | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1.50M 10-K · filed 2026-03-24 | |||||
| 2024-12-31 | $1.57M 10-K · filed 2026-03-24 | |||||
| 2023-12-31 | $1.67M 10-K · filed 2025-03-31 | $1.67B 10-K · filed 2024-02-08 | ||||
| 2022-12-31 | $1.57M 10-K · filed 2024-02-08 | $1.57B 10-K · filed 2023-03-13 | ||||
| 2021-12-31 | $1.35M 10-K · filed 2023-03-13 | $1.35B 10-K · filed 2022-02-24 | ||||
| 2020-12-31 | $336.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $736.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.24M derived: sum of 3 quarters · filed 2022-02-24 | $1.34M 10-K · filed 2022-02-24 | ||
| 2020-09-30 | $400.00K 10-Q · filed 2020-11-10 | $900.00K derived: sum of 2 quarters · filed 2020-11-10 | $1.00M 10-Q · filed 2020-11-10 | |||
| 2020-06-30 | $500.00K 10-Q · filed 2020-08-04 | $700.00K 10-Q · filed 2020-08-04 | ||||
| 2019-12-31 | $202.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $502.00K derived: sum of 2 quarters · filed 2022-02-24 | $802.00K derived: sum of 3 quarters · filed 2022-02-24 | $1.00M 10-K · filed 2022-02-24 | ||
| 2019-09-30 | $300.00K 10-Q · filed 2020-11-10 | $600.00K derived: sum of 2 quarters · filed 2020-11-10 | $800.00K 10-Q · filed 2020-11-10 | |||
| 2019-06-30 | $300.00K 10-Q · filed 2020-08-04 | $400.00K 10-Q · filed 2020-08-04 | $500.00K 10-Q · filed 2019-08-09 | |||
| 2019-03-31 | $200.00K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |